Send us Feedback

NeuroMetrix (NURO)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
NeuroMetrix Enters Exclusive Distribution Agreement with Handok Pharmaceuticals in Republic of Korea
Benzinga  Mar 12  Comment 
NeuroMetrix (NASDAQ: NURO) announced that it has entered an agreement with Handok Pharmaceuticals, Inc. Under terms of the agreement, Handok will be the exclusive distributor for NC-stat® DPNCheck™ in the Republic of Korea....
NEUROMetrix (NURO) Files $20M Mixed Shelf
StreetInsider.com  Feb 25  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/NEUROMetrix+%28NURO%29+Files+%2420M+Mixed+Shelf/8130151.html for the full story.
NeuroMetrix (NURO) Approves One-for-Six Reverse Split
StreetInsider.com  Feb 15  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/NeuroMetrix+%28NURO%29+Approves+One-for-Six+Reverse+Split/8106940.html for the full story.
NeuroMetrix Closes 510(k) Clearance Process for SENSUS
Benzinga  Nov 29  Comment 
NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, reported that it has received 510(k) clearance from the U.S. Food and Drug...
NeuroMetrix (NURO) Enters New Distribution Agreement for SENSUS
StreetInsider.com  Nov 1  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/NeuroMetrix+%28NURO%29+Enters+New+Distribution+Agreement+for+SENSUS/7833357.html for the full story.
NeuroMetrix (NURO) Gets Six-Month Extension to Regain Listing Compliance w/ Nasdaq
StreetInsider.com  Sep 20  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/NeuroMetrix+%28NURO%29+Gets+Six-Month+Extension+to+Regain+Listing+Compliance+w+Nasdaq/7741127.html for the full story.
NeuroMetrix (NURO) SENSUS Pain Management Device Receives Gets FDA 510(k) Clearance
StreetInsider.com  Aug 6  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/NeuroMetrix+%28NURO%29+SENSUS+Pain+Management+Device+Receives+Gets+FDA+510%28k%29+Clearance/7633691.html for the full story.
NeuroMetrix Files 510(k) for SENSUS™ Pain Therapy Device
Benzinga  Apr 18  Comment 
NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes reported today that it has filed a premarket notification, or 510(k), with the Food and Drug...
UPDATE: Neurometrix (NURO) Reports Large Order from Wal-Mart Canada
StreetInsider.com  Apr 2  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/UPDATE%3A+Neurometrix+%28NURO%29+Reports+Large+Order+from+Wal-Mart+Canada/7312439.html for the full story.
NeuroMetrix Initiative to Support American Diabetes Association Alert Day�
TheStreet.com  Mar 20  Comment 
NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of neurological complications of diabetes announced a patient initiative to support American Diabetes Association Alert Day ® which is...




more ▼WIKI ANALYSIS
 
TOP CONTRIBUTORS
Sr. Director
Greg Aurand
www.zacks.com

NeuroMetrix is a science-based medical device company advancing patient care through the development and marketing of innovative medical devices products that aid physicians in the assessment and treatment of diseases and injuries of peripheral nerves, and that provide regional anesthesia and pain control. The company's primary offering is technologies for the assessment of neuropathies. Neuropathies are disorders that affect the peripheral nerves and occur for a variety of reasons, including nerve entrapment (carpal tunnel syndrome), systemic disorders (diabetes) and spinal disk herniation compressing spinal nerve roots. NeuroMetrix's initial neuropathy evaluation device, the NC-stat® System, has been on the market since May 1999 and is used in over 5,000 physician's offices and clinics in the United States for performance of nerve conduction studies. The ADVANCE™ NCS/EMG System is a comprehensive platform for the performance of traditional nerve conduction studies and needle electromyography procedures which is used by specialist physicians with peripheral nerve expertise.




References

Retrieved from "http://www.wikinvest.com/stock/NeuroMetrix_(NURO)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki